|
Markt geschlossen -
Hong Kong S.E.
10:08:16 16.10.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 8.880 HKD | +0.17% |
|
-2.26% | +5.34% |
| 15.10. | CSPC Pharma erhält chinesische Genehmigung für Studie zu Tumormedikament | MT |
| 15.10. | CSPC Pharmaceutical Group Limited erhält Genehmigung für klinische Prüfung der SYS6088-Injektion in China | CI |
ETFs investiert in CSPC Pharmaceutical Group Limited
| Name | % 1. Jan. | Gewichtung | Volumen | |
|---|---|---|---|---|
| +11.20% | - | 27 154 M€ | ||
| +7.56% | - | 274 M€ | ||
| +16.98% | - | 4 070 M€ | ||
| -1.40% | - | 21 M€ | ||
| +10.33% | - | 67 M€ | ||
| +12.96% | - | 122 M€ | ||
| +16.08% | - | 182 M€ | ||
| -1.15% | - | 283 M€ | ||
| -2.84% | 4.14% | 5 M€ | ||
| +9.15% | 3.2% | 169 M€ | ||
| -14.37% | 2.29% | 65 M€ | ||
| +8.90% | 1.68% | 124 M€ | ||
| -25.21% | 1.51% | 5 M€ | ||
| +10.30% | 1.32% | 249 M€ | ||
| +24.26% | 1.16% | 886 M€ | ||
| +2.14% | 1.02% | 272 M€ | ||
| -.--% | 0.86% | 111 M€ | ||
| -12.36% | 0.86% | 511 M€ | ||
| -13.16% | 0.75% | 251 M€ | ||
| +14.81% | 0.63% | 89 M€ | ||
| +18.50% | 0.59% | 153 M€ | ||
| -12.71% | 0.58% | 85 M€ | ||
| -9.60% | 0.57% | 50 M€ | ||
| +13.19% | 0.54% | 27 M€ | ||
| -7.05% | 0.47% | 244 M€ | ||
| +17.30% | 0.47% | 174 M€ | ||
| +16.97% | 0.47% | 2 223 M€ | ||
| +35.03% | 0.45% | 47 M€ | ||
| +27.21% | 0.45% | 172 M€ | ||
| -13.39% | 0.43% | 89 M€ | ||
| +10.54% | 0.43% | 792 M€ | ||
| -14.77% | 0.4% | 6 244 M€ | ||
| +18.14% | 0.39% | 156 M€ | ||
| +13.68% | 0.37% | 3 246 M€ |
Beschäftigte
18’626
Sektor
Pharmazeutika
Termine
20.10.
Ex-Dividenden-Tag - 0.18 HKD
- Börse
- Aktien
- 548183 Aktie
- ETFs CSPC Pharmaceutical Group Limited
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
















